Research
June 28, 2022
NIH Funds UAMS Study Testing Rapid Genomic Surveillance for Antibiotic Resistant Infections
A University of Arkansas for Medical Sciences (UAMS) study is developing real-time and accurate genomic methods that can be used routinely to deliver life-saving information to doctors treating antibiotic-resistant infections. Backed by a two-year, $418,000 National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grant, UAMS’ Se-Ran Jun, Ph.D., says the…
June 27, 2022
UAMS’ Eric Peterson, Ph.D., Named Executive Vice President of BioVentures LLC
LITTLE ROCK — Eric Peterson, Ph.D., has been named executive vice president of BioVentures LLC at the University of Arkansas for Medical Sciences (UAMS). Peterson is chair of the UAMS Patent and Copyright Committee and is an associate professor in the College of Medicine Department of Pharmacology and Toxicology. As executive vice president, he will…
June 22, 2022
NCI Funds UAMS Study of Possible Links between Gammaherpesvirus Infections and Lymphomas
LITTLE ROCK — A possible link between gammaherpesviruses and lymphomas will receive further study at the University of Arkansas for Medical Sciences (UAMS) with a National Cancer Institute (NCI) grant. The five-year, $1.25 million grant renewal will mostly support ongoing work to better understand how gammaherpesvirus promotes mutations (chromosomal translocations) that lead to lymphomas. In…
June 10, 2022
Cancer Institute Retreat Highlights Novel Therapeutic Targets and Agents
The Winthrop P. Rockefeller Cancer Institute held its second annual scientific research retreat May 26 at the Marriott Hotel in Little Rock. More than 140 scientists gathered in person for the first time in two years. The retreat theme, “Molecular Targets and Cancer Therapeutics,” reflects the growth in the identification of new and novel molecular…
June 9, 2022
Arkansas Undergraduates ‘Speed Date’ with Research at UAMS Obesity and Diabetes Workshop
The University of Arkansas for Medical Sciences (UAMS) presented undergraduate students with an opportunity to learn more about obesity and diabetes at a uniquely structured workshop May 25. The workshop, hosted by Arkansas INBRE (IDeA Network of Biomedical Research Excellence), was attended by 15 students from around the state. There were presentations from seven UAMS…
June 7, 2022
UAMS, CAVHS Studying Health Effects of Arkansas Veterans’ Exposure to Burn Pits in Middle East
LITTLE ROCK — More than 300 Arkansas veterans will become part of a new study conducted by the University of Arkansas for Medical Sciences (UAMS) and the Central Arkansas Veterans Healthcare System (CAVHS) to determine if exposure to open pit burning and molecular-level changes are associated with chronic health conditions. The Department of Veterans Affairs…
June 2, 2022
UAMS Study First to Test When Common Arsenic Exposures Are Most Likely to Cause Male Infertility in Offspring
LITTLE ROCK — In the first study of its kind, researchers at the University of Arkansas for Medical Sciences (UAMS) will test when exposure to inorganic arsenic — a common, harmful environmental toxin — is most likely to lead to infertility traits that may last for generations. The study, supported by a five-year, $2.54 million…
June 1, 2022
Study Shows That Arkansas Minorities Experienced Abnormally High Rates of COVID-19 Infection
LITTLE ROCK — Researchers from multiple Arkansas agencies conducted an eight-month study which revealed that the state’s Hispanic and Black populations had higher COVID-19 infection rates than whites. This project, which Open Forum Infectious Disease published, used seroprevalence of antibodies to COVID-19 as an indicator. Antibodies are created by a person’s immune system once they…
May 26, 2022
Four UAMS Faculty Receive 2022 Provost’s Innovator Awards
The University of Arkansas for Medical Sciences (UAMS) announced four UAMS faculty as recipients of the Provost’s Innovator Awards. The awards were established by Stephanie Gardner, Pharm.D., Ed.D., UAMS provost and chief strategy officer, and Shuk-Mei Ho, Ph.D., vice chancellor for Research and Innovation. The grants of $25,000 each support groundbreaking, innovative, high-impact projects that…
May 23, 2022
UAMS Begins Final Study of First Rapid Test for Acetaminophen Toxicity with $3.2 Million Grant
The first rapid diagnostic test for acetaminophen toxicity has cleared a major hurdle on its long road to the marketplace from UAMS.
Next page